This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.15% per year. These returns cover a period from January 1, 1988 through March 4, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Zacks News
Lazard (LAZ) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Lazard (LAZ) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Lazard's (LAZ) February AUM Improves 1.7% on Upbeat Market
by Zacks Equity Research
Lazard's (LAZ) AUM balance in February benefits from a positive market, offset by net outflows and foreign exchange depreciation.
Moody's (MCO) Up 6.2% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Moody's (MCO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Lazard (LAZ) Hurt by Advisory Revenues, Rising Net Outflows
by Zacks Equity Research
Lazard's (LAZ) over-dependence on financial advisory revenues and continued net outflows are major headwinds.
Lazard's (LAZ) January AUM Declines 1.1% on Net Outflows
by Zacks Equity Research
Lazard Inc. (LAZ) witnesses a 1.1% AUM dip in January 2024 due to adverse foreign exchange impact and outflows.
Lazard (LAZ) Q4 Earnings Beat Estimates, Stock Rises 5.4%
by Zacks Equity Research
Lazard's (LAZ) Q4 earnings reflect higher revenues and strong AUM balances. Nonetheless, a rise in expenses and lower cash balance are headwinds.
Lazard (LAZ) Reports Q4 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
The headline numbers for Lazard (LAZ) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Lazard (LAZ) Q4 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Lazard (LAZ) delivered earnings and revenue surprises of 88.57% and 16.10%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate PJT Partners (PJT) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
PJT Partners (PJT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Countdown to Lazard (LAZ) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS
by Zacks Equity Research
Get a deeper insight into the potential performance of Lazard (LAZ) for the quarter ended December 2023 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
Analysts Estimate Lazard (LAZ) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Lazard (LAZ) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Rising Net Outflows, Concentration Risk Hurt Lazard (LAZ)
by Zacks Equity Research
Rising net outflows hurt Lazard's (LAZ) assets under management growth. Also, high dependence on financial advisory revenues is concerning due to growing uncertainty in the global markets.
Lazard (LAZ), Elaia Enter Negotiations for Strategic Partnership
by Zacks Equity Research
Lazard (LAZ) and Elaia enter exclusive negotiations to form a strategic partnership and launch a private investment platform.
Invesco (IVZ) Surges 7.6%: Is This an Indication of Further Gains?
by Zacks Equity Research
Invesco (IVZ) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Lazard's (LAZ) November AUM Increases 7.2% to $235.9 Billion
by Zacks Equity Research
Lazard (LAZ) records a 7.2% sequential increase in its November AUM due to market and FX appreciation, partially offset by net outflows.
Lazard's (LAZ) October AUM Falls 3.6% on Unfavorable Markets
by Zacks Equity Research
Lazard (LAZ) records a 3.6% sequential decline in October AUM due to market and FX depreciation and net outflows.
Lazard (LAZ) Q3 Earnings & Revenues Miss, Expenses Dip Y/Y
by Zacks Equity Research
Lazard's (LAZ) Q3 results were hurt by a decline in revenues and the AUM balance.
Lazard (LAZ) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
by Zacks Equity Research
The headline numbers for Lazard (LAZ) give insight into how the company performed in the quarter ended September 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Lazard (LAZ) Lags Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Lazard (LAZ) delivered earnings and revenue surprises of -47.37% and 10.30%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Franklin Resources (BEN) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Franklin Resources (BEN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Estimate Lazard (LAZ) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Lazard (LAZ) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Cohen & Steers' (CNS) September AUM Falls on Unfavorable Markets
by Zacks Equity Research
Cohen & Steers (CNS) records a 6.1% sequential decline in September AUM due to market depreciation and net outflows.
AllianceBernstein's (AB) August AUM Dips on Weak Markets
by Zacks Equity Research
Subdued markets performance results in a fall in AllianceBernstein's (AB) AUM balance in August.
Lazard's (LAZ) August AUM Falls 2.9% on Challenging Markets
by Zacks Equity Research
Lazard's (LAZ) August AUM declines 2.9% to $237.3 billion due to a challenging market backdrop.
Cohen & Steers' (CNS) August AUM Falls on Unfavorable Markets
by Zacks Equity Research
Cohen & Steers (CNS) records a 2.8% sequential decline in August 2023 AUM because of market depreciation and distributions.